Approval · Notice of Compliance 19143 · 2017
DOLOREX: Notice of Compliance 19143
Issued April 10, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19143
- Date
- April 10, 2017
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- TORBUGESIC (Wyeth Animal Health, Division Of Wyeth Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOLOREX | 02462923 | Marketed |
Medicinal ingredients
- BUTORPHANOL TARTRATE 10 MG per ML